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a  b  s  t  r  a  c  t
Since  the  1950s,  the  chemotherapy  of animal  African  trypanosomosis  in  cattle  has essen-
tially  relied  on only  two  compounds:  isometamidium  chloride  (ISM),  a  phenanthridine,
and  diminazene  aceturate,  an aromatic  diamidine.  The  commercial  formulations  of  ISM,
including  Veridium® and  Samorin®, are  a mixture  of  different  compounds:  ISM  is  the  major
component,  mixed  with  the  red isomer,  blue  isomer  and  disubstituted  compound.  To inves-
tigate  the pharmacological  effects  of  these  individual  compounds  ISM, the  blue and  red
isomers  and  the  disubstituted  compound  were  synthesised  and  puriﬁed  by HPLC.  The  activ-
ity of  each  compound  was  analysed  both  in vitro,  and  in  mice  in  vivo.  For  the  in  vitro  analysis,
a  drug  sensitivity  assay  was  developed  in 96-well  tissue  culture  plates to determine  the
effective concentration  which  killed  50%  of  trypanosome  population  within  48 h  of  drug
exposure  (IC50). All  compounds  tested  in  vitro  possessed  trypanocidal  activity,  and  puriﬁed
ISM  was  the  most  active.  Veridium® and Samorin® had  similar  IC50 values  to  puriﬁed  ISM
for both  Trypanosoma  congolense  and  Trypanosoma  brucei  brucei.  The  disubstituted  com-
pound  had  the  highest  IC50 values  whereas  intermediate  IC50 values  were  obtained  for  the
blue and  red  isomers.  In vivo,  single-dose  tests  were  used  to  evaluate  the  trypanocidal  and
prophylactic  activity  against  T. congolense.  Interestingly,  the  prophylactic  effect  two months
post treatment  was  as  efﬁcient  with  ISM,  Veridium®, Samorin® and the  disubstituted  com-
pound at  the highest  dose  of 1 mg/kg  whereas  the  red  and  blue  isomers  both  showed  much
lower  prophylactic  activity.  This  study  on  T. congolense  implies  that  it is  necessary  to  limit
the quantity  of  the  blue  and  red  isomers  in the  commercial  mixture.  Finally,  the in  vitro
sensitivity  assay  may  be  useful  for screening  new  trypanocides  but also for the  testing  and
detection  of  resistant  trypanosome  isolates.
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African trypanosomosis is a parasitic disease caused
by ﬂagellated protozoa of the order of Kinetoplastidae
and genus Trypanosoma. Trypanosomes are transmitted to
mammals by tsetse ﬂies and are responsible for the dis-
eases Nagana in cattle and sleeping sickness in humans. The



























































control (cells without drug). The half-maximal inhibitory
concentrations (IC50) were calculated using Sigmaplot12.5A. Sahin et al. / Veterinary
athogenic agents for animal African trypanosomosis in
attle are Trypanosoma congolense,  Trypanosoma vivax, and
o a lesser extent, Trypanosoma brucei brucei.  No vaccine is
vailable, thus chemotherapy remains the most commonly
mployed method to control trypanosomosis.
Among available drugs for animal trypanosomo-
is, diminazene aceturate is used therapeutically, and
sometamidium chloride (ISM) is used both therapeutically
nd prophylactically. Despite the fact that ISM has been
n the market for more than 50 years, very little is known
bout the precise mode of action of this compound. It has
reviously been shown that ISM is associated with the kine-
oplast in T. congolense and T. b. brucei (Boibessot et al.,
002; Wilkes et al., 1997) and that the mitochondrial elec-
rical potential was responsible for the ISM uptake in T.
ongolense. However, other targets must also exist, since
ome dyskinetoplastic strains of Trypanosoma evansi and
rypanosoma equiperdum are sensitive to ISM (Kaminsky
t al., 1997).
The synthesis of the commercial form of ISM
including Veridium® and Samorin®) results in a
ixture of compounds including: isometamidium
8-(3-m-amidinophenyl-2-triazeno)-3-amino-
-ethyl-6-phenylphenanthridinium chloride
ydrochloride, M&B4180A], the red isomer
3-(3-m-amidinophenyl-2-triazeno)-8-amino-5-ethyl-
-phenylphenanthridinium chloride hydrochloride,
&B38897], blue isomer [7-(m-amidinophenyldiazo)-
,8-diamino-5-ethyl-6-phenylphenanthridinium
hloride hydrochloride, M&B4250] and disubstituted
ompound [3,8-di(3-m-amidinophenyltriazeno)-5-ethyl-
-phenylphenanthridinium chloride dihydrochloride,
&B4596] (Fig. 1). Although the quantity of each com-
ound differs between the commercial products, it has
een shown that ISM is always the major component and
he disubstituted compound is the least abundant (Schad
t al., 2008).
Some limited studies with chemically synthesised com-
ounds have previously endeavoured to identify the effect
f these, and other phenanthridine compounds against try-
anosomes (Brown et al., 1961). However, the limitations
f the puriﬁcation and analytical methods available at the
ime made it difﬁcult to obtain pure compounds, thus the
ata collected on the pharmacological effects of each indi-
idual compound is uncertain (Kinabo and Bogan, 1988).
etermining the effects of the puriﬁed individual com-
ounds is necessary in order to understand the efﬁcacy,
ioavailability and toxicological effects of the commercial
ormulations of ISM.
In the current study, the efﬁcacy of three major by-
roducts of ISM synthesis was compared to puriﬁed ISM, as
ell as the commercial products, Veridium® and Samorin®.
or the ﬁrst time, the red and blue isomers and the
isubstituted compound were synthesised, puriﬁed by
PLC and tested individually for trypanocidal activity
gainst T. congolense and T. b. brucei in vitro, in addi-
ion to analysis of trypanocidal and prophylactic activity
gainst T. congolense in vivo. Analysis of trypanocidal activ-
ty in vitro necessitated the development of a 96-well
ensitivity test to determine IC50 values of the individual
ompounds.logy 203 (2014) 270–275 271
2. Materials and methods
2.1. Trypanosome strains and culture conditions
T. congolense IL1180, T. congolense IL3000 (kindly pro-
vided by the International Livestock Research Institute,
Nairobi, Kenya) and T. b. brucei Antat 1.1 strains were used
for this study. T. congolense IL3000 and T. b. brucei Antat 1.1
bloodstream forms were used since the cultures of these
strains are standardised (Baltz et al., 1985; Coustou et al.,
2010). T. congolense IL1180 was used for in vivo sensitivity
tests since it causes a chronic infection in mice (Coustou
et al., 2010) and was  previously used as a reference drug-
sensitive strain for Samorin® uptake studies (Peregrine
et al., 1988) since it is ISM sensitive (Hirumi, 1993).
2.2. Drugs
Isometamidium (M&B 4180A), the blue isomer (M&B
4250), red isomer (M&B 38897) and disubstituted com-
pound (M&B 4596) were synthesised and puriﬁed by
Provence Technologies SAS (Hôtel Technologique-BP100,
Technopôle de Château-Gombert, 13382 Marseille Cedex
13-France). The compounds were analysed, and structures
conﬁrmed by LC/MS (M+) and NMR  (1H and 13C). Respec-
tive purities were 99.7%, 97.6%, 95.4% and 97.9% for ISM,
the blue isomer, red isomer and disubstituted compound.
Veridium®, Samorin® and the compounds were dissolved
in distilled water (10 mg/ml) and stored at −20 ◦C. For
in vitro drug sensitivity tests, drugs were subsequently
diluted in the trypanosome culture medium.
2.3. In vitro drug sensitivity tests
Prior to the drug sensitivity tests, observation of the
general growth patterns of T. congolense IL3000 and T.
b. brucei Antat 1.1 in 96-well plates for 72 h established
that an inoculum of 4000 cells was  optimal for exponential
growth for 48 h. Parasites, counted using a haemocytome-
ter (4000/well, 100 l), were added to 96-well plates and
incubated at 34 ◦C (T. congolense)  or 37 ◦C (T. b. brucei)  with
4% CO2 for ∼4 h before addition of drugs. The drugs were
initially dissolved in water (10 mg/ml) and serial dilutions
made in culture media (1:10). Each dilution of drug (100 l)
was added to 100 l of culture in wells (duplicates were
made for each dilution from 1 mg/ml  until 1.10−19 mg/ml).
Subsequently, parasites were cultivated under the afore-
mentioned conditions for 24 and 48 h. The number of
viable cells in culture was quantiﬁed using the CellTiter-
Glo® Luminescent Cell Viability assay (Promega) according
to the manufacturer’s instructions. Brieﬂy, CellTiter-Glo®
(100 l) substrate was  added to each well, plates were
placed on an orbital shaker to induce lysis and subsequently
incubated at room temperature (10 min). Luminescent sig-
nal was measured using the Fluostar Optima at 405 nm.
The background value (medium only) was subtracted. The
quantity of live cells was  calculated as a percentage of the(Systat Software, Inc.). Two  independent experiments were
conducted for each strain.
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s. (A) Iso
brucei.
Isometamidium (IC50 0.56 ± 0.05 ng/ml) displayed
comparable trypanocidal activity to Veridium®
(0.82 ± 0.25 ng/ml) and Samorin® (IC50 1.75 ± 0.50 ng/ml)
Table 1
IC50 values from in vitro sensitivity tests after 48 h of drug exposure.
Mean IC50 (ng/ml) ± SDa
T. congolense IL3000 T. b. brucei Antat 1.1
Isometamidium 0.56 ± 0.05 9.24 ± 2.13
Red isomer 3.63 ± 0.55 202.15 ± 62.92
Blue isomer 7.11 ± 0.76 12.01 ± 2.22
Disubstituted
compound
66.27 ± 14.37 >1000
Veridium® 0.82 ± 0.25 11.06 ± 3.02Fig. 1. Chemical structures of isometamidium and its synthetic impuritie
(M&B 38897); (D) Disubstituted compound (M&B 4596).
2.4. In vivo drug sensitivity tests
All animal procedures were carried out in strict accor-
dance with the French legislation (Rural Code articles L
214-1 to L 214-122 and associated penal consequences)
and European Union (2010/63/EU) guidelines for the care
of laboratory animals and were approved by the Ethical
Committee of Bordeaux (C2EA-50) and by the University
of Bordeaux 2 animal care and use committee. All efforts
were made to minimise animal suffering.
Female Swiss mice (CD1) were purchased from Charles
River (L’Arbresle, France) and used for experiments at eight
weeks of age. A single-dose test was used to evaluate
the trypanocidal activity of the drugs (Eisler et al., 2001).
Brieﬂy, groups of ﬁve mice (two for non-treated control
groups) were infected by intraperitoneal (i.p.) inoculation
with 105 trypanosomes (T. congolense IL1180) diluted in
200 l phosphate-buffered saline-glucose (137 mM NaCl,
10 mM phosphate, 2.7 mM KCl, pH 7.4, 1% glucose). Mice
were treated 24 h after infection. Each drug was adminis-
tered by i.p. inoculation at concentrations of either 1 mg/kg
or 0.1 mg/kg of body-weight. Given the similar results
obtained for Samorin® and Veridium® at 1 mg/kg, only
Veridium® was tested at the lower dose (0.1 mg/kg). Non-
treated control mice only received sterile water (100 l)
post infection. Parasitaemia was monitored microscop-
ically from mouse tail blood twice weekly, and based
on the observation of at least 10 ﬁelds at 400× mag-
niﬁcation. To evaluate the prophylactic effect, mice that
were parasite negative after one month were re-infected
with 105 trypanosomes. The re-infection was repeated
after the second and third months post the initial infec-
tion and treatment if mice were consistently parasite
negative. Parasites for the re-infections were obtained
from chronically infected control mice in order to avoid
immediate immune clearance due to the presence of
homologous anti-VSG antibodies. Two non-treated micemetamidium (M&B 4180 A); (B) Blue isomer (M&B 4250); (C) Red isomer
were infected at each infection and re-infection point.
Treatment was considered inefﬁcient when more than
2 out of 5 mice within a group were positive for para-
sites.
3. Results
3.1. In vitro sensitivity of T. congolense and T. b. brucei to
Veridium®, Samorin®, isometamidium, red isomer, blue
isomer, and the disubstituted compound
Veridium®, Samorin®, puriﬁed ISM, the red and blue
isomers and the disubstituted compound, have been tested
individually for in vitro efﬁcacy against T. congolense
(Fig. 2a) and T. brucei (Fig. 2b) at 24 (not shown) and 48 hs of
drug exposure. Parasite viability and IC50 values (Table 1)
were calculated. All the compounds displayed varied levels
of trypanocidal activity against both T. congolense and T. b.Samorin® 1.75 ± 0.50 11.78 ± 4.88
a IC50 values were obtained by calculation with Sigmaplot 12. Data rep-
resent the mean and standard deviation of two separate experiments with
two  replicates each.
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tig. 2. In vitro sensitivity of (A) Trypanosoma congolense IL3000 and (B) T. b.
fter  48 h of drug exposure. T. congolense or T. b. brucei cells (4000) were a
or  48 h. The number of viable cells in culture was determined by quantiﬁc
ell  Viability assay.
gainst T. congolense. The blue and red isomers (IC50
.11 ± 0.76 ng/ml and 3.63 ± 0.55 ng/ml respectively)
xhibited similar trypanocidal activities, but both were
en times less effective than Veridium® and Samorin®. The
isubstituted compound was the least potent trypanocide
IC50 66.27 ± 14.37 ng/ml).
For T. b. brucei,  ISM and the blue isomer (IC50 9.24 ± 2.13,
2.01 ± 2.22 ng/ml respectively) had comparable activity
o Veridium® (11.06 ± 3.02 ng/ml) and Samorin® (IC50
1.78 ± 4.88 ng/ml). Similar to T. congolense,  the red isomer
as 10 times less effective (IC50 202.15 ± 62.92 ng/ml) and
he disubstituted compound 100 times less potent than ISM
espectively (IC50 > 1000 ng/ml).
.2. In vivo sensitivity of T. congolense to Veridium®,
amorin®, ISM, red isomer, blue isomer, disubstituted
ompound
The trypanocidal and prophylactic activity of
eridium®, Samorin®, puriﬁed ISM and the red and
lue isomers and disubstituted compound were individu-
lly tested in vivo in mice by monitoring the survival rate
fter four infections with 105 T. congolense IL1180 parasites
Table 2). The ﬁrst infection 24 h before treatment assessed
rypanocidal activity, whereas the subsequent challenges
ave an indication of prophylactic activity. All the com-
ounds, except the disubstituted compound at a dose of
.1 mg/kg, protected mice from the initial infection 24 h
ost-treatment. Samorin®, Veridium® and ISM proved to
e very similar in terms of prophylactic activity in vivo,
rotecting mice from two challenges, the last being two
onths post treatment. The disubstituted isomer, while
howing no trypanocidal activity at a dose of 0.1 mg/kg,
isplayed similar prophylactic activity to Samorin® and
eridium® at the higher dose of 1 mg/kg. The blue isomer
id not show any prophylactic effect at either of the
ested doses whereas the red isomer showed partial
rophylactic activity at the highest dose, one month post
reatment.ntat 1.1 bloodstream form parasites to isometamidium and its derivatives
 96-well tissue culture plates. After 4 h at 34 ◦C, drugs were added to cells
 the ATP present in culture medium with the CellTiter-Glo® Luminescent
4. Discussion
In the present study, the efﬁcacy of the commercial
products Veridium® and Samorin® were compared to pure
ISM, and its synthetic by-products, the red and blue iso-
mers and the disubstituted compound (Tettey et al., 1999).
Trypanocidal activity was  measured in vitro and in vivo and
prophylactic activity tested by survival of mice in vivo.
To test the trypanocidal properties of these compounds
in vitro, a new drug sensitivity test in 96-well tissue culture
plates was developed which will be very useful for rapid
screening of new trypanocides, or for any general assays of
inhibitors or growth promoting factors. Although labora-
tory tools for the detection of in vitro drug sensitivity have
been described previously (Delespaux et al., 2008; Gray and
Peregrine, 1993; Hirumi, 1993), the technique proposed in
this paper is simple and the least time-consuming.
ISM, Veridium®and Samorin® all showed similar try-
panocidal activity in vitro against T. b. brucei and T.
congolense. Signiﬁcantly, the by-products displayed lower
trypanocidal activities than pure ISM, since the two  isomers
and the disubstituted compound had IC50 values approxi-
mately 10-fold and 118-fold higher than ISM respectively
against T. congolense.  For this reason, the presence of these
by-products at high quantities (the red and blue isomers
may  together constitute up to 40% of the ﬁnal product,
(Schad et al., 2008) in commercial preparations of ISM is
concerning given the prevalence of ISM-resistant T. con-
golense strains (Delespaux et al., 2008). Interestingly, the
in vitro results indicated that T. b. brucei was 15-fold less
sensitive to ISM than T. congolense.  Since it is known that
a difference in mitochondrial energy metabolism exist-
ing among trypanosomatids (Tielens and van Hellemond,
2009); and that the mitochondrial electrical potential may
play a role in ISM uptake (Wilkes et al., 1997); this could
explain the different level of sensitivity between T. con-
golense and T. b. brucei.
Two different doses of the compounds (0.1 and 1 mg/kg)
were used for the in vivo studies to approximate the range
of the doses used in the ﬁeld (Diarra et al., 1998), either
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Table 2
In vivo sensitivity of T. congolense IL1180 to isometamidium and its derivatives at two different doses.
Drug Dose (mg/kg) Number of parasite positive mice/total
Number of successive infectionsa
1 2 3 4
Samorin® 1 0/5 0/5 1/5 5/5
Veridium® 0.1 0/5 0/5 0/4b 4/4b
1 0/5 0/5 1/5 5/5
Isometamidium 0.1  0/5 0/5 0/5 5/5
1  0/5 0/5 0/5 5/5
Red  isomer 0.1 0/5 5/5 NDc ND
1  0/5 1/5 5/5 ND
Blue  isomer 0.1 0/5 5/5 ND ND
1  0/5 4/5 5/5 ND
Disubstituted
compound
0.1  5/5 ND ND ND
1  0/5 0/5 1/5 4/5
Non-treatedd – 2/2 2/2 2/2 2/2
a Mice were infected with 105 parasites and treated 24 h later to study the trypanocidal effect. Mice which were negative for parasites after the ﬁrst
month,  and each subsequent month were re-infected to establish the duration of prophylactic activity.
b One mouse died following the second infection changing the group total to 4.
er grou
ntrols.c Not done: treatment was considered inefﬁcient if more than 2 mice p
d Two  mice were infected at each infection and re-infection point as co
for trypanocidal treatment or prophylaxis, which also dif-
fers depending on the sensitivity of the strain (Gray et al.,
1993; Peregrine et al., 1988; Wilkes et al., 1997). Since the
commercial products may  contain as little as 6% of some of
the by-products (disubstituted compound), the lower dose
(0.1 mg/kg) is more representative of dose rates achieved
for the by-products under ﬁeld conditions when animals
are dosed at 0.5–1 mg/kg with the commercial mixtures.
In terms of trypanocidal effect, the in vivo results at the
doses tested with the ISM-sensitive strain, conﬁrmed the
in vitro tests to the extent that all the compounds tested
were active except for the disubstituted compound at a
lower concentration The disubstituted compound had an
IC50 118-fold higher than ISM in vitro, therefore, it was
not surprisingly that higher dose would be required for a
similar level of trypanocidal activity to ISM in vivo.
ISM, Veridium®and Samorin® and the disubstituted
compound (at 1 mg/kg only) showed similar prophylactic
activities against T. congolense challenge in mice in vivo.
This prophylactic activity achieved at 1 mg/kg with the
disubstituted compound could be explained by the fact
that the disubstituted compound acts like a pro-drug and
may  be cleaved in vivo to produce ISM. Although the
disubstituted compound was known to be prophylactic
(Brown et al., 1961), the current study demonstrated that
this activity is highly dose-dependent. For this reason, it
is crucial to note that a standard dose of commercial ISM
products contains less than 0.1 mg/kg of the disubstituted
compound (Schad et al., 2008), which would be insufﬁ-
cient for a trypanocidal effect. Furthermore, the red and
blue isomers, the most abundant by-products (40%) of the
commercial products (Schad et al., 2008), have lower pro-
phylactic activities providing only partial protection at one
month post treatment.
It is known that qualitative and quantitative differences
exist between the different commercial forms of ISM which
may  arise due to a variety of factors, including temperaturep were infected.
and pH, during the manufacturing process (Berg, 1963).
This study has demonstrated that these variations are of
serious concern since underdosing of ISM or a competition
between the red or blue isomers with ISM could increase
the risk for the development of drug resistance. Further-
more, the in vivo and in vitro results with T. congolense
indicated that the red and blue isomers, the most abun-
dant compounds in synthesis other than ISM, have poor
trypanocidal and prophylactic activity. For these reasons,
it is essential to establish guidelines to modulate the quan-
tity of the various by-products in the ﬁnal mixture of the
commercial product. This could be achieved by altering the
conditions during the manufacturing process. For example,
it is known that a pH of 1.8–2.2 in the reaction medium cor-
relates with an increase in the quantity of ISM, whereas a
higher pH results in a greater production of the blue isomer
(Berg, 1963; Tettey et al., 1999). Thus, optimisation of the
manufacturing process, and the strict adherence thereof,
would be necessary to control the quantities of the by-
products.
The data generated by this study will be very useful to
improve the understanding of the efﬁcacy and bioavailabil-
ity or biotransformation of the commercial formulations of
ISM and help to develop new drug compositions with opti-
mal  ratios for an improved trypanocidal and prophylactic
effects.
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